Trial of Methylphenidate and Thioridazine
Abstract
A double-blind, placebo-controlled, cross-over study of methylphenidate (0.4 mg/kg/day) and thioridazine (1.75 mg/kg/day) in 27 intellectually subaverage children is reported from The Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State Univ., Columbus, OH, and the University of Aukland, New Zealand.
DOI: https://doi.org/10.15844/pedneurbriefs-5-9-11 | Journal eISSN: 2166-6482
Language: English
Page range: 72 - 72
Published on: Sep 1, 1991
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1991 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.